ZabBio is focused on the development of monoclonal antibody-based products aimed at addressing significant gaps in the treatment of infectious diseases and reproductive health. The company emphasizes its commitment to producing these products at scale and at a cost-effective price, ensuring that they are accessible to large, cost-sensitive markets. This approach highlights ZabBio's dedication to meeting the healthcare needs of diverse populations while maintaining affordability.

Currently, ZabBio has a contraceptive product, ZB-06, in development, with additional products expected to be introduced in the near future. The company’s pipeline indicates a strategic focus on expanding its offerings in reproductive health, alongside its efforts in combating infectious diseases. This dual focus underscores ZabBio's mission to innovate and provide solutions in critical areas of healthcare that are often underserved.

United States

ZabBio is a biopharmaceutical company that focuses on developing monoclonal antibody-based products to address unmet needs in infectious diseases and reproductive health, with a focus on large, cost-sensitive markets.

ZabBio

Company Details